Luyuan Ma

535 total citations
17 papers, 261 citations indexed

About

Luyuan Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Luyuan Ma has authored 17 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Luyuan Ma's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Luyuan Ma is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Luyuan Ma collaborates with scholars based in China, United States and Germany. Luyuan Ma's co-authors include Xiang Zhu, Xiaofeng Kang, Zhong Chu, Rui Cong, Nan Huo, Chunyuan Xue, Hanxiao Liu, Nan Du, Qihong Li and Hua You and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Medicine.

In The Last Decade

Luyuan Ma

14 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luyuan Ma China 8 188 159 50 31 27 17 261
Qiandong Zhu China 10 212 1.1× 168 1.1× 53 1.1× 25 0.8× 45 1.7× 14 309
Feiye Liu China 9 213 1.1× 148 0.9× 44 0.9× 29 0.9× 23 0.9× 13 294
Shi-Zhe Zhang China 6 215 1.1× 190 1.2× 49 1.0× 25 0.8× 38 1.4× 8 319
Jiayan Lian China 8 229 1.2× 190 1.2× 32 0.6× 19 0.6× 30 1.1× 10 304
Shyamananda Singh Mayengbam India 7 181 1.0× 200 1.3× 61 1.2× 33 1.1× 33 1.2× 8 331
Yimin Xiong China 10 248 1.3× 153 1.0× 59 1.2× 22 0.7× 38 1.4× 16 375
Juan L López-Cánovas Spain 9 182 1.0× 81 0.5× 24 0.5× 36 1.2× 26 1.0× 13 250
Yuandeng Luo China 8 184 1.0× 90 0.6× 67 1.3× 32 1.0× 53 2.0× 12 285

Countries citing papers authored by Luyuan Ma

Since Specialization
Citations

This map shows the geographic impact of Luyuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyuan Ma more than expected).

Fields of papers citing papers by Luyuan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luyuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyuan Ma. The network helps show where Luyuan Ma may publish in the future.

Co-authorship network of co-authors of Luyuan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Luyuan Ma. A scholar is included among the top collaborators of Luyuan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luyuan Ma. Luyuan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ma, Luyuan, Lixiang Ma, Xiao-Ting Li, et al.. (2025). Case Report: TAFRO syndrome misdiagnosed as liver cirrhosis due to persistent abdominal distension. Frontiers in Immunology. 16. 1554198–1554198.
2.
Zhang, Xiaotong, Zonghua Wang, Qiuting Wang, et al.. (2025). Global trends in carbapenem-resistant gram-negative bacteria research (2020–2025): a bibliometric analysis and systematic review. Frontiers in Cellular and Infection Microbiology. 15. 1690417–1690417.
3.
Ma, Luyuan, et al.. (2025). GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation. World Journal of Surgical Oncology. 23(1). 122–122. 1 indexed citations
4.
Qi, Xingshun, Feijun Luo, Dingxin Wang, et al.. (2025). TFIIB-related factor 2 inhibits lung squamous carcinoma cell apoptosis through SLC8A3-mediated mitochondrial homeostasis. Cell Death and Disease. 16(1). 491–491. 1 indexed citations
5.
Ma, Luyuan, Wenhao Yu, Fayez Kheir, et al.. (2024). Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma. Translational Lung Cancer Research. 13(6). 1346–1364.
6.
7.
Ma, Luyuan, et al.. (2023). FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma. Cellular Signalling. 111. 110828–110828. 4 indexed citations
8.
Wang, Yadong, Xing Zhang, Yue Luo, et al.. (2022). IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection. Frontiers in Public Health. 10. 911551–911551. 4 indexed citations
9.
Huo, Nan, Rui Cong, Wenchao Li, et al.. (2021). STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis. Cell Death and Disease. 12(9). 799–799. 69 indexed citations
10.
Chu, Zhong, Nan Huo, Xiang Zhu, et al.. (2021). FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect. Molecular Therapy. 29(9). 2737–2753. 88 indexed citations
11.
12.
Zhu, Xiang, An Xu, Nan Huo, et al.. (2020). <p>ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 10515–10523. 7 indexed citations
13.
Jia, Yanhong, Luyuan Ma, Yadong Wang, et al.. (2020). NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF. Molecular Immunology. 120. 179–186. 16 indexed citations
14.
Ma, Luyuan, Wenpeng Liu, An Xu, et al.. (2020). Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect. Cancer Science. 111(6). 2028–2040. 21 indexed citations
15.
16.
Yang, Xuhui, Xiang Zhu, Zhifeng Yan, et al.. (2019). miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential. Molecular Therapy — Oncolytics. 16. 30–40. 28 indexed citations
17.
Wang, Yadong, Lingling Wu, Luyuan Ma, et al.. (2019). Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman. Medicine. 98(2). e14032–e14032. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiandong Zhu Breakdown of academic impact, for papers by Feiye Liu Breakdown of academic impact, for papers by Shi-Zhe Zhang Breakdown of academic impact, for papers by Jiayan Lian Breakdown of academic impact, for papers by Shyamananda Singh Mayengbam Breakdown of academic impact, for papers by Yimin Xiong Breakdown of academic impact, for papers by Juan L López-Cánovas Breakdown of academic impact, for papers by Yuandeng Luo
Rankless by CCL
2026